# Evaluation of Sirolimus-Eluting, Heparin-Coated CoCr Stent in the Treatment of de Novo Coronary Artery Lesions in Small Vessels(EVOLUTION)

> **NCT00233779** · PHASE2 · COMPLETED · sponsor: **Cordis US Corp.** · enrollment: 52 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** SIROLIMUS-ELUTING, HEPARIN-COATED CoCr BALLOON-EXPANDABLE STENT

## Key facts

- **NCT ID:** NCT00233779
- **Lead sponsor:** Cordis US Corp.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-10
- **Primary completion:** —
- **Final completion:** 2004-12
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2007-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00233779

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00233779, "Evaluation of Sirolimus-Eluting, Heparin-Coated CoCr Stent in the Treatment of de Novo Coronary Artery Lesions in Small Vessels(EVOLUTION)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00233779. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*